Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Licenses Protein Purification Technique to ZymoGenetics

NEW YORK, Jan. 9 (GenomeWeb News) - Inproteo said today it has licensed a patent for a protein purification technique to ZymoGenetics.


ZymoGenetics' license to the so-called Smith patent, which protects the His tag fusion protein purification technique, covers all uses of the technology for the life of the patent.


Inproteo, formerly known as the Indiana Proteomics Consortium - a partnership between Indiana University, Purdue University, and Eli Lilly - recently obtained a license to the patent, U.S. Patent No. 4,569,794, from Eli Lilly. It holds the exclusive right to sublicense the patent and has already licensed it to a number of companies.


The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.